The Current Status of Direct Oral Anticoagulants in Cancer-Related Venous Thromboembolism Treatment

This article is a review of epidemiology, pathogenesis and treatment of venous thromboembolism (VTE) in cancer patients. In accordance with actual guidelines, the duration of anticoagulant therapy of cancer-related venous thrombosis should be at least 6 months. The use of vitamin K antagonists (VKA)...

Full description

Saved in:
Bibliographic Details
Main Authors: К. V. Lobastov, I. V. Schastlivtsev
Format: Article
Language:English
Published: Столичная издательская компания 2020-05-01
Series:Рациональная фармакотерапия в кардиологии
Subjects:
Online Access:https://www.rpcardio.online/jour/article/view/2177
Tags: Add Tag
No Tags, Be the first to tag this record!